Clinical trial
A Phase II Study of Preoperative Immunotherapy in Patients With Colorectal Cancer and Resectable Hepatic Metastases
NCT03844750 is registered in ClinicalTrials.gov with Chloe Atreya, MD, PhD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Preoperative Immunotherapy in Patients With Colorectal Cancer and Resectable Hepatic Metastases
- Lead sponsor
- Chloe Atreya, MD, PhD
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- July 22, 2019
- Completion date
- September 30, 2025
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic malignant neoplasm in the liver, stage iv colorectal cancer ajcc v8, stage iva colorectal cancer ajcc v8, stage ivb colorectal cancer ajcc v8, stage ivc colorectal cancer ajcc v8